TY  - JOUR 
AU  - Sezgin Bayindir, Zerrin
AU  - Losada Barreiro, Sonia
AU  - Bravo Díaz, Carlos Daniel
AU  - Sova, Matej
AU  - Kristl, Julijana
AU  - Saso, Luciano
PY  - 2021
SN  - 20763921
UR  - http://hdl.handle.net/11093/2797
AB  - The disadvantages of conventional anticancer drugs, such as their low bioavailability, poor targeting efficacy, and serious side effects, have led to the discovery of new therapeutic agents and potential drug delivery systems. In particular, the...
LA  - eng
PB  - Antioxidants
TI  - Nanotechnology-based drug delivery to improve the therapeutic benefits of NRF2 modulators in cancer therapy
DO  - 10.3390/antiox10050685
ER  -